AbbVie Is One Of The Largest Players In The TNF Alpha Inhibitors Market, According To The Business Research Company’s TNF Alpha Inhibitors Global Market Report 2020-30: COVID-19 Growth And Change
(Companies Covered: AbbVie Inc., Amgen Inc., Johnson & Johnson Services Inc., UCB S.A, Novartis International AG, Pfizer Inc., Merck & co. Inc., Janssen Biotech, Ablynx, Momenta Pharmaceuticals, Celgene Corporation)
The global TNF alpha inhibitors market is expected to decline from $40.66 billion in 2019 to $39.01 billion in 2020 at a compound annual growth rate of -4.06%. The decline is mainly due to the COVID-19 outbreak that has led to restrictive containment measures involving social distancing, remote working, and the closure of industries and other commercial activities resulting in operational challenges. The entire supply chain has been disrupted, impacting the market negatively. The market is then expected to recover and reach $42.86 billion in 2023 at a compound annual growth rate of 3.18%.
Read More On The Global TNF Alpha Inhibitors Market Report At –https://www.thebusinessresearchcompany.com/report/tnf-alpha-inhibitors-global-market-report-2020-30-covid-19-growth-and-change
The TNF alpha inhibitors market consists of sales of tumor necrosis factor-alpha (TNF-a) inhibitors by entities that manufacture TNF alpha inhibitors. TNF alpha inhibitors are a group of medicines that conquer the body’s natural response to TNF, a protein produced by white blood cells, involved in early inflammatory events.
Global TNF Alpha Inhibitors Market Segmentation –
1) By Drug: Remicade (infliximab), Enbrel (etanercept), Humira (adalimumab), Cimzia (certolizumab pegol), Simponi (golimumab).
2) By Route of Administration: Oral, Subcutaneous, Intravenous, Others.
3) By Disease Type: Inflammatory Bowel Disease, Psoriatic Arthritis, Ulcerative Colitis (UC), Rheumatoid Arthritis, Ankylosing Spondylitis, Others.
Global TNF Alpha Inhibitors Market Driver –
The growing prevalence of inflammatory diseases such as inflammatory bowel disease and psoriasis is a key factor driving the growth of the TNF alpha inhibitors market. Tumor necrosis factor-alpha (TNF alpha) inhibitors are commonly used in gastroenterology, dermatology and rheumatology for the treatment of various immune-mediated inflammatory diseases.
Request For A Sample Of The Global TNF Alpha Inhibitors Market Report At – https://www.thebusinessresearchcompany.com/sample.aspx?id=3459&type=smp
Few Points From The Global TNF Alpha Inhibitors Market TOC
1. Executive Summary
2. TNF Alpha Inhibitors Market Characteristics
3. TNF Alpha Inhibitors Market Size And Growth
3.1. Global TNF Alpha Inhibitors Historic Market, 2015 – 2019, $ Billion
3.1.1. Drivers Of The Market
3.1.2. Restraints On The Market
4. TNF Alpha Inhibitors Market Segmentation
4.1. Global TNF Alpha Inhibitors Market, Segmentation By Drug, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
5. TNF Alpha Inhibitors Market Regional And Country Analysis
5.1. Global TNF Alpha Inhibitors Market, Split By Region, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
5.2. Global TNF Alpha Inhibitors Market, Split By Country, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
6. Asia-Pacific TNF Alpha Inhibitors Market
6.1. Asia-Pacific TNF Alpha Inhibitors Market Overview
6.2. Asia-Pacific TNF Alpha Inhibitors Market, Segmentation By Drug, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
Interested to know more about The Business Research Company?
The Business Research Company is a market intelligence firm that excels in company, market, and consumer research. Located globally it has specialist consultants in a wide range of industries including manufacturing, healthcare, financial services, chemicals, and technology.
Company Name: The Business Research Company
Contact Person: Oliver Guirdham
Email: Send Email
Phone: +44 20 7193 0708
State: Greater London
Country: United Kingdom